Department of Medical Humanities, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Dutch Cystic Fibrosis Foundation (NCFS), Dr. A. Schweitzerweg 3A, 3744 MG Baarn, The Netherlands.
Development. 2020 Apr 6;147(7):dev177972. doi: 10.1242/dev.177972.
Organoids are three-dimensional multicellular structures grown from stem cells and which recapitulate some organ function. They are derivatives of living tissue that can be stored in biobanks for a multitude of research purposes. Biobank research on organoids derived from patients is highly promising for precision medicine, which aims to target treatment to individual patients. The dominant approach for protecting the interests of biobank participants emphasizes broad consent in combination with privacy protection and (predictive) ethics review. In this paradigm, participants are positioned as passive donors; however, organoid biobanking for precision medicine purposes raises challenges that we believe cannot be adequately addressed without more ongoing involvement of patient-participants. In this Spotlight, we argue why a shift from passive donation towards more active involvement is particularly crucial for biobank research on organoids aimed at precision medicine, and suggest some approaches appropriate to this context.
类器官是由干细胞生长而成的三维多细胞结构,可再现某些器官功能。它们是活体组织的衍生物,可以储存在生物库中,用于多种研究目的。源于患者的类器官的生物库研究对精准医学极具前景,因为精准医学旨在针对个体患者进行治疗。保护生物库参与者利益的主要方法是强调广泛同意,结合隐私保护和(预测)伦理审查。在这种模式下,参与者被定位为被动供体;然而,出于精准医学目的的类器官生物库存储提出了一些挑战,我们认为,如果没有患者参与者更多的持续参与,这些挑战将无法得到充分解决。在本专题中,我们认为为什么从被动捐献向更积极的参与转变对于旨在用于精准医学的类器官的生物库研究尤为重要,并针对这种情况提出了一些适当的方法。